Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Brain Dev ; 46(5): 207-212, 2024 May.
Article in English | MEDLINE | ID: mdl-38448301

ABSTRACT

BACKGROUND AND OBJECTIVES: Niemann-Pick type C (NPC) is a rare lysosomal storage disease characterized by hepatosplenomegaly and progressive neurological deterioration due to abnormal intracellular cholesterol transport. Cyclic oligosaccharide 2-hydroxypropyl-ß-cyclodextrin (HPBCD) is an effective treatment for NPC; however, few reports have shown its long-term efficacy and safety. To demonstrate long-term efficacy and safety of intrathecal HPBCD (IT-HPBCD) treatment for NPC, we herein reports five patients with NPC treated using IT-HPBCD for 4-11 years. CASES AND RESULTS: Patients' ages at the onset ranged from 1.5 to 20 years. Notably, all patients showed rapid disease progression despite treatment with miglustat before IT-HPBCD treatment. Similarly, some patients showed transient improvement; however, all patients' conditions stabilized after long-term IT-HPBCD therapy. Mild-to-moderate hearing loss was observed in three patients. Furthermore, long-term treatment with IT-HPBCD may suppress neurological deterioration in patients with NPC; however, patients still experience some disease progression. CONCLUSIONS: Long-term treatment with IT-HPBCD may suppress neurological deterioration in patients with NPC; however, the treatment outcome is dependent on the neurological status at the time of diagnosis, and disease progression is not completely inhibited. Awareness of the disease and newborn screening is needed for earlier disease detection. In addition, further optimization of the treatment protocol and additional treatments are needed to improve patient outcomes.


Subject(s)
Cyclodextrins , Niemann-Pick Disease, Type C , Infant, Newborn , Humans , Niemann-Pick Disease, Type C/drug therapy , Cyclodextrins/therapeutic use , 2-Hydroxypropyl-beta-cyclodextrin/therapeutic use , Treatment Outcome , Disease Progression
2.
Brain Dev ; 45(3): 191-195, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36529612

ABSTRACT

INTRODUCTION: Patients with Chiari I malformation (CM1) may have chronic symptoms of syringomyelia, including numbness and weakness of the upper limbs, typically during young adulthood. Acute or subacute presentation of unilateral foot drop has been rarely reported as a first symptom of CM1-associated syringomyelia exclusively in childhood or adolescence. Why these patients do not show any symptoms of the upper limbs although holocord syringomyelia is always observed on magnetic resonance imaging (MRI) is unclear. CASE PRESENTATION: A four-year-old girl presented rapidly with isolated left foot drop. Conventional MRI revealed holocord syringomyelia associated with CM1. Three-dimensional constructive interference in steady state (3D-CISS) imaging further demonstrated that the syringomyelia was comprised of two differential cavities that communicated with each other via a small pore: a centrally positioned upper cavity and a left-deviated lower one. Surgical decompression of the foramen magnum resolved the symptom with radiological improvement of the two cavities. CONCLUSION: In contrast to a centrally enlarged syrinx that is often asymptomatic, a paracentrally extended syrinx usually produces segmental signs related to its levels. Thus, the left foot drop in this case would have been due to the ipsilaterally deviated lower cavity that was distinguished from the central upper cavity by 3D-CISS imaging. Further reports using this imaging technique are needed to verify the hypothetic pathology.


Subject(s)
Arnold-Chiari Malformation , Peroneal Neuropathies , Syringomyelia , Female , Adolescent , Humans , Child , Young Adult , Adult , Child, Preschool , Syringomyelia/complications , Syringomyelia/diagnostic imaging , Peroneal Neuropathies/complications , Peroneal Neuropathies/surgery , Arnold-Chiari Malformation/complications , Arnold-Chiari Malformation/diagnostic imaging , Magnetic Resonance Imaging , Decompression, Surgical/methods
4.
Brain Dev ; 44(8): 583-587, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35562277

ABSTRACT

BACKGROUND: Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with aphasia is a rare disorder, with the associated aphasia reported as either Wernicke's or Broca's. Herein, we report a patient with MELAS complicated by thalamic aphasia. CASE: A 15-year-old right-handed girl presented with headache, nausea, right homonymous hemianopsia, and aphasia. She could repeat words said by others, but had word-finding difficulty, paraphasia, and dysgraphia. Brain MRI revealed abnormal signals from the left occipital lobe to the temporal lobe and left thalamus, but Wernicke's area and Broca's area were not involved. Additionally, she had short stature, lactic acidosis, bilateral sensorineural hearing loss, and a maternal family history of diabetes and mild deafness. Based on clinical findings and the presence of a mitochondrial A3243G mutation, she was diagnosed with MELAS. With treatment, the brain MRI lesions disappeared and her symptoms improved. Her aphasia was classified as amnesic aphasia because she could repeat words, despite having word-finding difficulty, paraphasia, and dysgraphia. Based on MRI findings of a left thalamic lesion, we diagnosed her with thalamic aphasia. CONCLUSION: Thalamic aphasia may be caused by MELAS. Assessment of whether repetition is preserved is important for classifying aphasia.


Subject(s)
Acidosis, Lactic , Agraphia , Aphasia , MELAS Syndrome , Stroke , Acidosis, Lactic/complications , Adolescent , Aphasia/etiology , Female , Humans , MELAS Syndrome/complications , MELAS Syndrome/diagnosis , Mitochondrial Encephalomyopathies , Stroke/complications , Stroke/diagnostic imaging , Thalamus/diagnostic imaging
5.
Brain Dev ; 44(1): 36-43, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34362595

ABSTRACT

OBJECTIVE: To clarify the incidence and risk factors of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in pediatric patients with febrile status epilepticus (FSE). METHODS: We retrospectively surveyed patients with FSE (≥20 min and ≥40 min) who were younger than 6 years by mailing a questionnaire to 1123 hospitals in Japan. The survey period was 2 years. We then collected clinical data on patients with prolonged febrile seizures (PFS) ≥40 min and those with AESD, and compared clinical data between the PFS and AESD groups. RESULTS: The response rate for the primary survey was 42.3%, and 28.0% of hospitals which had applicable cases responded in the secondary survey. The incidence of AESD was 4.3% in patients with FSE ≥20 min and 7.1% in those with FSE ≥40 min. In the second survey, a total of 548 patients had FSE ≥40 min (AESD group, n = 93; PFS group, n = 455). Univariate analysis revealed significant between-group differences in pH, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, creatine kinase, NH3, procalcitonin (PCT), uric acid, blood urea nitrogen, creatinine (Cr), and lactate. Multivariate analysis using stratified values showed that high PCT was an only risk factor for AESD. A prediction score of ≥3 was indicative of AESD, as determined using the following indexes: HCO3- < 20 mmol/L (1 point), Cl <100 mEq/L (1 point), Cr ≥0.35 mg/dL (1 point), glucose ≥200 mg/dL (1 point), and PCT ≥1.7 pg/mL (2 points). The scoring system had sensitivity of 84.2% and specificity of 81.0%. CONCLUSION: Incidence data and prediction scores for AESD will be useful for future intervention trials for AESD.


Subject(s)
Brain Diseases/diagnosis , Brain Diseases/epidemiology , Seizures, Febrile/diagnosis , Seizures, Febrile/epidemiology , Status Epilepticus/diagnosis , Status Epilepticus/epidemiology , Child, Preschool , Epilepsy/diagnosis , Female , Hospitals/statistics & numerical data , Humans , Incidence , Infant , Japan/epidemiology , Male , Retrospective Studies , Risk Factors
7.
Plant Cell Physiol ; 62(9): 1460-1477, 2021 Nov 17.
Article in English | MEDLINE | ID: mdl-34184745

ABSTRACT

Aluminum (Al)-tolerant tobacco cell line ALT301 derived from SL (wild-type) hardly exhibits Al-triggered reactive oxygen species (ROS) compared with SL. Molecular mechanism leading to this phenotype was investigated comparatively with SL. Under normal growth condition, metabolome data suggested the activation of glycolysis and lactate fermentation but the repression of the tricarboxylic acid (TCA) cycle in ALT301, namely aerobic fermentation, which seemed to be transcriptionally controlled partly by higher expression of genes encoding lactate dehydrogenase and pyruvate dehydrogenase kinase. Microarray and gene ontology analyses revealed the upregulation of the gene encoding related to APETALA2.3 (RAP2.3)-like protein, one of the group VII ethylene response factors (ERFVIIs), in ALT301. ERFVII transcription factors are known to be key regulators for hypoxia response that promotes substrate-level ATP production by glycolysis and fermentation. ERFVIIs are degraded under normoxia by the N-end rule pathway of proteolysis depending on both oxygen and nitric oxide (NO), and NO is produced mainly by nitrate reductase (NR) in plants. In ALT301, levels of the NR gene expression (NIA2), NR activity and NO production were all lower compared with SL. Consistently, the known effects of NO on respiratory pathways were also repressed in ALT301. Under Al-treatment condition, NO level increased in both lines but was lower in ALT301. These results suggest that the upregulation of the RAP2.3-like gene and the downregulation of the NIA2 gene and resultant NO depletion in ALT301 coordinately enhance aerobic fermentation, which seems to be related to a higher capacity to prevent ROS production in mitochondria under Al stress.


Subject(s)
Aluminum/pharmacology , Fermentation , Nicotiana/physiology , Drug Tolerance , Fermentation/drug effects , Fermentation/genetics , Gene Expression Regulation, Plant , Plant Proteins/genetics , Plant Proteins/metabolism , Nicotiana/genetics
8.
Brain Dev ; 43(7): 809-813, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33958241

ABSTRACT

BACKGROUND: Transient periictal MRI abnormalities (TPMA) are caused by seizures, and may completely or partially reverse within a few days following seizure. Although TPMA are usually observed in patients with status epilepticus (SE), they have also been rarely reported after isolated/recurrent seizures not fulfilling the criteria for SE. Herein, we present a case of a 1-year-old girl with TPMA. CASE: A 1-year-old girl with Apert syndrome and epilepsy showed MRI abnormalities in the cortico-subcortical areas of the left temporal, occipital and parietal lobes, as well as the left thalamus. These abnormalities showed as a hyperintense signal on diffusion-weighted imaging and a hypointense signal on apparent-diffusion coefficient maps. On follow-up MRI after 3 days, the abnormal signals were completely reversed. We confirmed TPMA after eliminating other possibilities. When treatment was withdrawn, the patient regained consciousness immediately and did not show any abnormality on subsequent MRI. CONCLUSION: TPMA may occur in young children; recognizing this possibility is important for making the diagnosis and conducting appropriate treatment. As a previous study revealed, the distribution of signal changes in cortico-subcortical areas and the ipsilateral thalamus may be a characteristic feature of TPMA.


Subject(s)
Acrocephalosyndactylia/surgery , Epilepsy/diagnostic imaging , Epilepsy/pathology , Electroencephalography , Epilepsy/physiopathology , Epilepsy/therapy , Female , Humans , Infant , Magnetic Resonance Imaging
9.
Sci Rep ; 11(1): 1552, 2021 01 15.
Article in English | MEDLINE | ID: mdl-33452387

ABSTRACT

Moyamoya disease (MMD) is characterized by progressive bilateral stenotic changes in the terminal portion of the internal carotid arteries. Although RNF213 was identified as a susceptibility gene for MMD, the exact pathogenesis remains unknown. Immunohistochemical analysis of autopsy specimens from a patient with MMD revealed marked accumulation of hyaluronan and chondroitin sulfate (CS) in the thickened intima of occlusive lesions of MMD. Hyaluronan synthase 2 was strongly expressed in endothelial progenitor cells in the thickened intima. Furthermore, MMD lesions showed minimal staining for CS and hyaluronan in the endothelium, in contrast to control endothelium showing positive staining for both. Glycosaminoglycans of endothelial cells derived from MMD and control induced pluripotent stem cells demonstrated a decreased amount of CS, especially sulfated CS, in MMD. A computational fluid dynamics model showed highest wall shear stress values in the terminal portion of the internal carotid artery, which is the predisposing region in MMD. Because the peri-endothelial extracellular matrix plays an important role in protection, cell adhesion and migration, an altered peri-endothelial matrix in MMD may contribute to endothelial vulnerability to wall shear stress. Invading endothelial progenitor cells repairing endothelial injury would produce excessive hyaluronan and CS in the intima, and cause vascular stenosis.


Subject(s)
Endothelial Cells/metabolism , Moyamoya Disease/physiopathology , Adenosine Triphosphatases/metabolism , Adolescent , Aged , Biomechanical Phenomena/physiology , Carotid Artery, Internal/pathology , Carotid Intima-Media Thickness , Chondroitin Sulfates/analysis , Endothelial Cells/physiology , Endothelium/metabolism , Female , Genetic Predisposition to Disease , Humans , Hyaluronic Acid/analysis , Hydrodynamics , Induced Pluripotent Stem Cells/metabolism , Male , Moyamoya Disease/metabolism , Shear Strength/physiology , Stress, Mechanical , Ubiquitin-Protein Ligases/metabolism
10.
Cardiovasc Interv Ther ; 36(4): 547-548, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33119837
11.
Brain Dev ; 43(3): 482-485, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33248857

ABSTRACT

Paroxysmal abnormal eye movement in early infancy is one of the initial symptoms of glucose transporter 1 deficiency syndrome (GLUT1DS). We describe four early infants with transient hypoglycorrhachia presenting with abnormal eye movements. Their symptoms disappeared after the introduction of a ketogenic diet (KD), and their development was normal. Since no variants in SLC2A1 were detected, the CSF-to-blood glucose ratios (C/B) were re-examined, and within normal range. None of the four patients displayed recurrent symptoms after withdrawal from the KD. Because long-term KD has potential adverse effects and could affect the quality of life of patients and their families, re-examination of CSF glucose during late infancy should be considered in the case of absence of the SLC2A1 pathogenic variant.


Subject(s)
Glucose/cerebrospinal fluid , Ocular Motility Disorders , Diet, Ketogenic , Humans , Infant, Newborn , Male
13.
Sci Rep ; 10(1): 8446, 2020 06 11.
Article in English | MEDLINE | ID: mdl-32528026

ABSTRACT

The release of rhizodeposits differs depending on the root position and is closely related to the assimilated carbon (C) supply. Therefore, quantifying the C partitioning over a short period may provide crucial information for clarifying root-soil carbon metabolism. A non-invasive method for visualising the translocation of recently assimilated C into the root system inside the rhizobox was established using 11CO2 labelling and the positron-emitting tracer imaging system. The spatial distribution of recent 11C-photoassimilates translocated and released in the root system and soil were visualised for white lupin (Lupinus albus) and soybean (Glycine max). The inputs of the recently assimilated C in the entire root that were released into the soil were approximately 0.3%-2.9% for white lupin within 90 min and 0.9%-2.3% for soybean within 65 min, with no significant differences between the two plant species; however, the recently assimilated C of lupin was released at high concentrations in specific areas (hotspots), whereas that of soybean was released uniformly in the soil. Our method enabled the quantification of the spatial C allocations in roots and soil, which may help to elucidate the relationship between C metabolism and nutrient cycling at specific locations of the root-soil system in response to environmental conditions over relatively short periods.


Subject(s)
Carbon/metabolism , Glycine max/metabolism , Lupinus/metabolism , Plant Roots/metabolism , Positron-Emission Tomography/methods , Rhizosphere , Biological Transport , Botany/instrumentation , Carbon Cycle , Carbon Dioxide/metabolism , Carbon Radioisotopes/analysis , Equipment Design , Positron-Emission Tomography/instrumentation , Radioactive Tracers , Soil/chemistry , Species Specificity
14.
Mod Rheumatol ; 30(3): 551-557, 2020 May.
Article in English | MEDLINE | ID: mdl-31116057

ABSTRACT

Background: IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. The pathogenesis of this disease is not clear. Transcriptome analysis was performed to identify genes over- and under-expressed in patients with IgG4-RD.Method: DNA microarray analysis was performed using RNA from peripheral blood mononuclear cells of two patients with IgG4-RD and four healthy individuals. Genes showing a greater than threefold change in expression in IgG4-RD patients following steroid therapy were identified. Four genes related to innate immunity such as transcobalamin I (TCN1), secretory leukocyte peptidase inhibitor (SLPI), bactericidal/permeability-increasing protein (BPI) and lactotransferrin (LTF) were assessed by real-time PCR in 15 IgG4-RD patients and 13 healthy individuals.Result: DNA microarray analysis identified 30 genes showing a greater than threefold change in expression in IgG4-RD patients following steroid therapy. Real-time RT-PCR showed that the levels of mRNAs encoding TCNI and SLPI, except for BPI and LTF, were significantly lower in patients with IgG4-RD than in healthy people. The levels of all four mRNAs in patients with IgG4-RD were significantly increased after steroid treatment.Conclusion: These results indicate that reduction in expression of innate immunity-related genes may participate in the pathogenesis of IgG4-RD that steroid treatment may rectify impaired innate immunity as well as acquired immunity.


Subject(s)
Immunity, Innate/genetics , Immunoglobulin G4-Related Disease/genetics , Transcriptome , Adult , Female , Humans , Immunoglobulin G4-Related Disease/metabolism , Lactoferrin/genetics , Lactoferrin/metabolism , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Secretory Leukocyte Peptidase Inhibitor/genetics , Secretory Leukocyte Peptidase Inhibitor/metabolism , Transcobalamins/genetics , Transcobalamins/metabolism
16.
Brain Dev ; 41(1): 111-115, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30104084

ABSTRACT

Subacute combined degeneration of the spinal cord (SACD) is a rare neurologic disorder manifesting progressive symptoms of paresthesia and spastic paralysis. Herein we present an autopsy case of SACD caused by folic acid and copper deficiency. A 16-year-old male presented with gradually worsening unsteady gait, and bladder and rectal dysfunction. He had a medical history of T-cell acute lymphoblastic leukemia (T-ALL), diagnosed 1.5 years previously. The patient had undergone chemotherapy, including methotrexate, as well as allogeneic bone mallow transplantation. Laboratory tests revealed normal vitamin B12 and methylmalonic acid concentration, but reduced serum copper, ceruloplasmin and folic acid concentrations. Magnetic resonance imaging revealed symmetrical T2 signal hyperintensities in the posterior and lateral spinal cord. The patient was treated with oral copper, oral folate, and intravenous vitamin B12. A month after this treatment, the patient's symptoms were unchanged, and 2 months later he died of acute adrenal insufficiency. The pathological findings of the spinal cord were compatible with SACD. Because SACD is usually reversible with early treatment, it should be suspected in high-risk patients undergoing chemotherapy or those who are malnourished with characteristic symptoms of SACD, even in young patients.


Subject(s)
Copper/deficiency , Folic Acid Deficiency/complications , Subacute Combined Degeneration/etiology , Adolescent , Adrenal Insufficiency , Fatal Outcome , Folic Acid Deficiency/diagnostic imaging , Folic Acid Deficiency/pathology , Folic Acid Deficiency/therapy , Humans , Male , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Spinal Cord/diagnostic imaging , Spinal Cord/pathology , Subacute Combined Degeneration/diagnostic imaging , Subacute Combined Degeneration/pathology , Subacute Combined Degeneration/therapy
17.
Mod Rheumatol ; 27(3): 381-391, 2017 May.
Article in English | MEDLINE | ID: mdl-28165852

ABSTRACT

IgG4-related disease (IgG4-RD) is a fascinating clinical entity proposed by Japanese investigators, and includes a wide variety of diseases, formerly diagnosed as Mikulicz's disease (MD), autoimmune pancreatitis (AIP), interstitial nephritis, prostatitis, retroperitoneal fibrosis, etc. Although all clinicians in every field of medicine may encounter this new disease, a unifying diagnostic criterion has not been established. In 2011, the Japanese IgG4 team, organized by the Ministry of Health, Labor and Welfare (MHLW) of Japan, published comprehensive diagnostic criteria for IgG4-RD. Several problems with these criteria have arisen in clinical practice, however, including the difficulty obtaining biopsy samples from some patients, and the sensitivity and the specificity of techniques used to measure serum IgG4 concentrations. Although serum IgG4 concentration is an important clinical marker for IgG4-RD, its diagnostic utility in differentiating IgG4-RD from other diseases, called IgG4-RD mimickers, remains unclear. This review describes the current optimal approach for the diagnosis of IgG4-RD, based on both comprehensive and organ-specific diagnostic criteria, in patients with diseases such as IgG4-related pancreatitis (AIP), sclerosing cholangitis, and renal, lung and orbital diseases.


Subject(s)
Autoimmune Diseases/diagnosis , Immunoglobulin G/blood , Autoimmune Diseases/blood , Autoimmune Diseases/immunology , Diagnosis, Differential , Humans , Immunoglobulin G/immunology , Japan
18.
J Agric Food Chem ; 64(43): 8084-8094, 2016 Nov 02.
Article in English | MEDLINE | ID: mdl-27726362

ABSTRACT

In this study, we determined the capacity of soybean (Glycine max L. Merr. cv. Hoyoharuka) and sorghum (Sorghum bicolor L. Moench. cv. Hybrid Sorgo) to utilize different forms of nitrogen (N) in a rhizobox system. Seedlings were grown for 35 days without N or with 130 mg N kg-1 soil as ammonium sulfate or farmyard cattle manure. The soil fractions at different distances from the root were sliced millimeter by millimeter in the rhizobox system. We assessed the distribution of different forms of N and microbial metabolism in different soil fractions in the rhizosphere. There are no treatment-dependent changes in biomass production in the roots and shoots of soybeans, however, the ammonium and manure treatment yielded 1.30 and 1.40 times higher shoot biomass of sorghum than the control. Moreover, the depletion of inorganic N and total amino acids (TAA) in the rhizosphere was largely undetectable at various distances from the soybean roots regardless of the treatments employed. The addition of ammonium sulfate resulted in a decrease in the nitrate concentration gradient as the distance decreased from the sorghum roots. The addition of manure to the soil increased the N content in the sorghum shoots, 1.57 times higher than the control; this increase was negatively correlated with the concentrations of TAA in the soil of the root compartment. In addition, the application of manure simultaneously induced TAA depletion (i.e., the TAA concentration in root compartment was 1.48 times higher than that in bulk soil) and greater microbial activity and diversity in the sorghum rhizosphere, where higher microbial consumption of asparagine, glutamic acid, and phenylalanine were also observed near the roots. Our results are first to present the evidence that sorghum may possess a high capacity for taking up amino acids as a consequence of organic matter application, and microbial metabolism.


Subject(s)
Glycine max/growth & development , Manure , Nitrogen/metabolism , Rhizosphere , Sorghum/growth & development , Amino Acids/analysis , Amino Acids/metabolism , Ammonium Sulfate , Animals , Cattle , Fertilizers , Japan , Microbial Consortia/physiology , Nitrogen/analysis , Sorghum/metabolism , Glycine max/metabolism
19.
Sci Rep ; 6: 35946, 2016 10 24.
Article in English | MEDLINE | ID: mdl-27775018

ABSTRACT

Soybean (Glycine max) is sensitive to flooding stress, and flood damage at the seedling stage is a barrier to growth. We constructed two mathematical models of the soybean metabolic network, a control model and a flooded model, from metabolic profiles in soybean plants. We simulated the metabolic profiles with perturbations before and after the flooding stimulus using the two models. We measured the variation of state that the system could maintain from a state-space description of the simulated profiles. The results showed a loss of variation of state during the flooding response in the soybean plants. Loss of variation of state was also observed in a human myelomonocytic leukaemia cell transcriptional network in response to a phorbol-ester stimulus. Thus, we detected a loss of variation of state under external stimuli in two biological systems, regardless of the regulation and stimulus types. Our results suggest that a loss of robustness may occur concurrently with the loss of variation of state in biological systems. We describe the possible applications of the quantity of variation of state in plant genetic engineering and cell biology. Finally, we present a hypothetical "external stimulus-induced information loss" model of biological systems.


Subject(s)
Environmental Exposure , Gene Regulatory Networks , Monocytes/metabolism , Plant Cells/metabolism , Biological Variation, Population , Gene Expression Profiling , Humans , Models, Theoretical , Glycine max/cytology , THP-1 Cells
20.
Cell Immunol ; 303: 50-4, 2016 05.
Article in English | MEDLINE | ID: mdl-27019130

ABSTRACT

Here, we established CD4(+)αßTh1 clones specific for rat vascular smooth muscle antigen (VSMAg) that induced vasculitis lesions in the lungs of MRL/Mp-Fas(+/+) mice following adoptive transfer. Six different T cell clones, MV1b1 (Vß1), MV1b4 (Vß4), MV1b8.3 (Vß8.3), MV1b61 (Vß6), MV1b62 (Vß6), and MV1b63 (Vß6), were isolated from the MV1 T cell line from the regional lymph nodes of immunized MRL/Mp-Fas(+/+) mice; the three (Vß6) clones had unique CDR3 amino acid sequences. Following stimulation with VSMAg-pulsed antigen presenting cells, MV1b61 and MV1b62 failed to secrete interferon-γ and tumor necrosis factor-α, although the other four clones secreted high levels of both cytokines. In adoptive transfer experiments, MV1b61 and MV1b62 did not induce organ involvement including pulmonary vasculitis. In contrast, MV1b1, MV1b4, MV1b8.3, and MV1b63 induced perivascular mononuclear cell infiltration in pulmonary small arteries. These clones may provide useful tools for investigating the underlying mechanisms of vasculitis syndromes and for developing therapeutic strategies.


Subject(s)
Lung/immunology , Th1 Cells/immunology , Vasculitis/immunology , Animals , Antigen-Presenting Cells/immunology , Antigens/immunology , Antigens/metabolism , CD4 Antigens/metabolism , Cell Movement , Clone Cells , Female , Immunization , Interferon-gamma/metabolism , Lung/blood supply , Mice , Mice, Inbred MRL lpr , Muscle, Smooth, Vascular/metabolism , Rats , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Th1 Cells/transplantation , Tumor Necrosis Factor-alpha/metabolism , fas Receptor/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...